Who
Marshall Fordyce
President and CEO
Company insider
Files Form 4 as: President and CEO, Vera Therapeutics.
In numbers
- Trades disclosed
- 258
- Buys
- 0
- Sells
- 35
- Bought
- $0
- Sold
- $33.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 May 2021
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $54K18,500 at $2.90 | filing |
| 15 Sep 2026filed 17 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $685K18,500 at $37.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,500 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,500 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $54K18,500 at $2.90 | filing |
| 15 Sep 2026filed 17 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $685K18,500 at $37.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $54K18,500 at $2.90 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $650K18,500 at $35.12 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,500 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,500 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $54K18,500 at $2.90 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $650K18,500 at $35.12 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $134K46,250 at $2.90 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $41K1,000 at $40.78 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.4M32,550 at $42.07 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —46,250 at $0.00 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $450K10,500 at $42.86 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $96K2,200 at $43.59 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —46,250 at $0.00 | filing |
| 7 Jul 2026filed 12 Aug 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $134K46,250 at $2.90 | filing |
News
Vera Therapeutics (NASDAQ:VERA) CEO Marshall Fordyce Sells 18,500 Sharestickerreport.com · 5 Sep 2026
1 headline in the last 90 days name Marshall Fordyce; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.